Akers Biosciences Inc. (AKER) is priced at $4.05 after the most recent trading session. At the very opening of the session, the stock price was $3.45 and reached a high price of $4.476, prior to closing the session it reached the value of $3.45. The stock touched a low price of $3.44.
Recently in News on January 28, 2021, INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on Behalf of Shareholders – XLNX, IPHI, NAV, AKER, INFO. Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:. You can read further details here
Akers Biosciences Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $4.48 on 02/10/21, with the lowest value was $2.00 for the same time period, recorded on 01/04/21.
Akers Biosciences Inc. (AKER) full year performance was 27.36%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Akers Biosciences Inc. shares are logging -54.24% during the 52-week period from high price, and 161.29% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.55 and $8.85.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 5652039 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Akers Biosciences Inc. (AKER) recorded performance in the market was 103.52%, having the revenues showcasing 134.10% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 33.45M, as it employees total of 12 workers.
Analysts verdict on Akers Biosciences Inc. (AKER)
During the last month, 0 analysts gave the Akers Biosciences Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.25, with a change in the price was noted +1.61. In a similar fashion, Akers Biosciences Inc. posted a movement of +65.98% for the period of last 100 days, recording 1,051,930 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for AKER is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Akers Biosciences Inc. (AKER): Technical Analysis
Raw Stochastic average of Akers Biosciences Inc. in the period of last 50 days is set at 83.65%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 78.76%. In the last 20 days, the company’s Stochastic %K was 87.59% and its Stochastic %D was recorded 87.92%.
Let’s take a glance in the erstwhile performances of Akers Biosciences Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 103.52%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -25.55%, alongside a boost of 27.36% for the period of the last 12 months. The shares increased approximately by 50.00% in the 7-day charts and went down by 74.57% in the period of the last 30 days. Common stock shares were driven by 134.10% during last recorded quarter.